These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Differential effect of local infusion of serotonin reuptake inhibitors in the raphe versus forebrain and the role of depolarization-induced release in increased extracellular serotonin. Tao R; Ma Z; Auerbach SB J Pharmacol Exp Ther; 2000 Aug; 294(2):571-9. PubMed ID: 10900234 [TBL] [Abstract][Full Text] [Related]
23. Effect of fenfluramine-induced increases in serotonin release on [18F]MPPF binding: a continuous infusion PET study in conscious monkeys. Udo de Haes JI; Harada N; Elsinga PH; Maguire RP; Tsukada H Synapse; 2006 Jan; 59(1):18-26. PubMed ID: 16237679 [TBL] [Abstract][Full Text] [Related]
24. Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis. McQuade R; Sharp T J Neurochem; 1997 Aug; 69(2):791-6. PubMed ID: 9231740 [TBL] [Abstract][Full Text] [Related]
25. Acute and chronic effects of citalopram on 5-HT1A receptor-labeling by [18F]MPPF and -coupling to receptors-G proteins. Moulin-Sallanon M; Charnay Y; Ginovart N; Perret P; Lanfumey L; Hamon M; Hen R; Fagret D; Ibáñez V; Millet P Synapse; 2009 Feb; 63(2):106-16. PubMed ID: 19016488 [TBL] [Abstract][Full Text] [Related]
26. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe. Dong J; De Montigny C; Blier P Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722 [TBL] [Abstract][Full Text] [Related]
27. Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus. Invernizzi R; Velasco C; Bramante M; Longo A; Samanin R Neuropharmacology; 1997; 36(4-5):467-73. PubMed ID: 9225271 [TBL] [Abstract][Full Text] [Related]
28. Aging alters in a region-specific manner serotonin transporter sites and 5-HT(1A) receptor-G protein interactions in hamster brain. Duncan MJ; Hensler JG Neuropharmacology; 2002 Jul; 43(1):36-44. PubMed ID: 12213257 [TBL] [Abstract][Full Text] [Related]
29. Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse. Knobelman DA; Hen R; Lucki I J Pharmacol Exp Ther; 2001 Sep; 298(3):1083-91. PubMed ID: 11504805 [TBL] [Abstract][Full Text] [Related]
30. Feedback stimulation of somatodendritic serotonin release: a 5-HT3 receptor-mediated effect in the raphe nuclei of the rat. Bagdy E; Solyom S; Harsing LG Brain Res Bull; 1998; 45(2):203-8. PubMed ID: 9443841 [TBL] [Abstract][Full Text] [Related]
31. Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor-treated depression: an [(18)F] MPPF positron emission tomography study. Praschak-Rieder N; Hussey D; Wilson AA; Carella A; Lee M; Dunn E; Willeit M; Bagby RM; Houle S; Meyer JH Biol Psychiatry; 2004 Oct; 56(8):587-91. PubMed ID: 15476688 [TBL] [Abstract][Full Text] [Related]
32. Functional regulation by dopamine receptors of serotonin release from the rat hippocampus: in vivo microdialysis study. Matsumoto M; Yoshioka M; Togashi H; Ikeda T; Saito H Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):621-9. PubMed ID: 8738295 [TBL] [Abstract][Full Text] [Related]
33. P-[18F]-MPPF: a potential radioligand for PET studies of 5-HT1A receptors in humans. Shiue CY; Shiue GG; Mozley PD; Kung MP; Zhuang ZP; Kim HJ; Kung HF Synapse; 1997 Feb; 25(2):147-54. PubMed ID: 9021895 [TBL] [Abstract][Full Text] [Related]
34. 5-HT autoreceptors in the regulation of 5-HT release from guinea pig raphe nucleus and hypothalamus. Moret C; Briley M Neuropharmacology; 1997; 36(11-12):1713-23. PubMed ID: 9517443 [TBL] [Abstract][Full Text] [Related]
35. Activation of 5-HT(1A) autoreceptors enhances the inhibitory effect of galanin on hippocampal 5-HT release in vivo. Yoshitake T; Yoshitake S; Yamaguchi M; Ogren SO; Kehr J Neuropharmacology; 2003 Feb; 44(2):206-13. PubMed ID: 12623219 [TBL] [Abstract][Full Text] [Related]
36. Serotonin neuronal release from dorsal hippocampus following electrical stimulation of the dorsal and median raphé nuclei in conscious rats. Mokler DJ; Lariviere D; Johnson DW; Theriault NL; Bronzino JD; Dixon M; Morgane PJ Hippocampus; 1998; 8(3):262-73. PubMed ID: 9662140 [TBL] [Abstract][Full Text] [Related]
37. Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors. Hjorth S; Auerbach SB Eur J Pharmacol; 1994 Aug; 260(2-3):251-5. PubMed ID: 7988652 [TBL] [Abstract][Full Text] [Related]
38. Measurement of 5-hydroxytryptamine release in the rat medial vestibular nucleus using in vivo microdialysis. Inoue S; Kita T; Yamanaka T; Ogawa Y; Nakashima T; Hosoi H Neurosci Lett; 2002 May; 323(3):234-8. PubMed ID: 11959427 [TBL] [Abstract][Full Text] [Related]
39. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone. Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724 [TBL] [Abstract][Full Text] [Related]
40. 5-HT1A receptor agonist effects of BMY-14802 on serotonin release in dorsal raphe and hippocampus. Matos FF; Korpinen C; Yocca FD Eur J Pharmacol; 1996 Dec; 317(1):49-54. PubMed ID: 8982718 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]